ADMA Adma Biologics Inc

ADMA Biologics Inc is a biopharmaceutical company. The Company develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases.

$1.82
As of 06/11/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/17/2013
Outstanding shares:  128,189,628
Average volume:  2,202,477
Market cap:   $237,150,812
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    000899104
ISIN:        US0008991046
Sedol:      B9NSBM2
Valuation   (See tab for details)
PE ratio:   -3.12
PB ratio:   1.99
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy